동물 줄기세포 치료 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Animal Stem Cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 6,944,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,142,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,810,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

전 세계 동물 줄기세포 치료 시장 규모는 2025년에 3억 610만 달러로 2025-2032년 예측 기간 동안 5.2%의 CAGR로 확대될 것으로 예상되며, 2032년에는 4억 3,730만 달러에 달할 것으로 예상됩니다.

동물 줄기세포 치료는 줄기세포를 이용하여 손상된 조직을 복구하여 골관절염, 힘줄 손상, 인대 손상, 염증성 질환 등 동물의 다양한 병증을 치료하는 혁신적인 치료법입니다. 이 치료법에서는 주로 골수, 지방조직, 제대혈 유래 중간엽 줄기세포(MSC)가 사용됩니다. 동물 줄기세포 치료 시장은 고급 재생 치료 옵션을 원하는 동물병원, 연구기관, 반려동물 보호자를 대상으로 합니다. 시장 성장의 원동력은 반려동물 사육 수의 증가, 재생치료에 대한 인식의 증가, 치료 성과와 접근성을 향상시키는 수의학 발전 등입니다.

세계 동물 줄기세포 치료 시장은 반려동물의 정형외과 질환 유병률 증가, 비침습적 치료 솔루션에 대한 수요 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 첨단 수의학적 치료와 줄기세포 치료의 이점에 대한 보호자들의 인식이 높아지면서 시장 확대의 또 다른 원동력이 되고 있습니다. 줄기세포 분리 및 냉동 보존 기술의 향상과 같은 기술적 발전은 치료 효과를 높이고 줄기세포의 적용 범위를 확대할 것입니다. 또한, 수의학적 재생의료에 대한 투자 증가와 생명공학 기업과 수의학 연구기관과의 공동연구도 시장 개척에 기여하고 있습니다.

동물 줄기세포 치료 시장은 재생의료의 지속적인 연구, 동물 의료비 증가, 맞춤형 치료 접근법의 시장 개척으로 큰 성장 기회를 가져오고 있습니다. 줄기세포 치료와 AI를 활용한 진단 및 원격의료와 같은 디지털 헬스 기술의 융합은 치료 모니터링과 환자 예후를 개선할 수 있습니다. 또한 자가면역질환, 신경질환, 상처 치유 등 줄기세포 치료의 적용 범위는 근골격계 질환 외에도 확대되고 있으며, 시장 관계자들에게 새로운 수익원을 창출하고 있습니다. 전략적 파트너십, R&D 투자, 비용 효율적인 줄기세포 치료의 도입은 새로운 기회를 포착하고 진화하는 동물용 헬스케어 시장에서 리더십을 유지하기 위해 필수적입니다.

세계의 동물 줄기세포 치료 시장을 조사했으며, 제품 유형별, 유래별, 용도별, 종류별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위와 정의
• 시장 역학
• 거시경제 요인
• COVID-19의 영향 분석
• 예측요인 - 관련성과 영향

제3장 부가가치 인사이트

제4장 세계의 동물 줄기세포 치료 시장 전망

• 주요 하이라이트
• 시장 규모 분석과 예측
• 세계의 동물 줄기세포 치료 시장 전망 : 제품 유형별
• 세계의 동물 줄기세포 치료 시장 전망 : 유래별
• 세계의 동물 줄기세포 치료 시장 전망 : 용도별
• 세계의 동물 줄기세포 치료 시장 전망 : 종별
• 세계의 동물 줄기세포 치료 시장 전망 : 최종사용자별

제5장 세계의 동물 줄기세포 치료 시장 전망 : 지역별

• 주요 하이라이트
• 과거 시장 규모 분석, 지역별, 2019-2024년
• 현재 시장 규모 분석과 예측, 지역별, 2025-2032년
• 시장 매력 분석 : 지역별

제6장 북미의 동물 줄기세포 치료 시장 전망

제7장 유럽의 동물 줄기세포 치료 시장 전망

제8장 동아시아의 동물 줄기세포 치료 시장 전망

제9장 남아시아 및 오세아니아의 동물 줄기세포 치료 시장 전망

제10장 라틴아메리카의 동물 줄기세포 치료 시장 전망

제11장 중동 및 아프리카의 동물 줄기세포 치료 시장 전망

제12장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
• 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Magellan Stem Cells
  • StemcellX
  • Boehringer Ingelheim(Global stem cell technology)
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC(Ardent Animal Health)
  • Medrego
  • AniCell Biotech
  • Gallant
  • Companion Animal Health
  • Kintaro Cells Power
  • StemBioSys
  • Regen BioPharma, Inc.
  • Celltex Therapeutics Corporation
  • Regenexx

제13장 부록

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for animal stem cell therapy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global animal stem cell therapy market from 2025 to 2032.

Key Insights:

• Animal Stem Cell Therapy Market Size (2025E): US$ 306.1 Mn
• Projected Market Value (2032F): US$ 437.3 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Animal Stem Cell Therapy Market - Report Scope:

Animal stem cell therapy is an innovative treatment approach that utilizes stem cells to repair damaged tissues and treat various medical conditions in animals, including osteoarthritis, tendon injuries, ligament damage, and inflammatory diseases. The therapy primarily involves the use of mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, or umbilical cord blood. The animal stem cell therapy market caters to veterinary clinics, research institutes, and pet owners seeking advanced regenerative treatment options. Market growth is driven by increasing pet adoption, rising awareness of regenerative therapies, and advancements in veterinary medicine enhancing treatment outcomes and accessibility.

Market Growth Drivers:

The global animal stem cell therapy market is propelled by several key factors, including the rising prevalence of orthopedic conditions in companion animals and the increasing demand for non-invasive treatment solutions. The growing awareness among pet owners regarding advanced veterinary care and the benefits of stem cell therapy further drive market expansion. Technological advancements, such as improved stem cell isolation and cryopreservation techniques, enhance treatment efficacy and expand the scope of stem cell applications. Additionally, increasing investments in veterinary regenerative medicine and research collaborations between biotech companies and veterinary institutions contribute to the market's rapid development.

Market Restraints:

Despite promising growth prospects, the animal stem cell therapy market faces challenges related to regulatory compliance, high treatment costs, and limited awareness in emerging markets. Stringent regulations governing stem cell therapies in veterinary applications impose compliance burdens on manufacturers and veterinary practitioners, affecting market penetration. Furthermore, the high cost of stem cell therapy, coupled with the lack of standardized protocols and reimbursement policies, limits accessibility for pet owners. Ethical concerns and the need for extensive clinical validation further pose barriers to market expansion, necessitating ongoing research and regulatory advancements.

Market Opportunities:

The animal stem cell therapy market presents significant growth opportunities driven by continuous research in regenerative medicine, increasing veterinary healthcare expenditure, and the development of personalized treatment approaches. The integration of stem cell therapy with digital health technologies, such as AI-driven diagnostics and telemedicine, enhances treatment monitoring and patient outcomes. Additionally, the expanding applications of stem cell therapy beyond musculoskeletal conditions, including autoimmune diseases, neurological disorders, and wound healing, create new revenue streams for market players. Strategic partnerships, investments in R&D, and the introduction of cost-effective stem cell therapies are essential to capitalize on emerging opportunities and sustain market leadership in the evolving veterinary healthcare landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the animal stem cell therapy market globally?
• Which stem cell types and applications are driving the adoption of stem cell therapy in veterinary medicine?
• How are technological advancements reshaping the competitive landscape of the animal stem cell therapy market?
• Who are the key players contributing to the animal stem cell therapy market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global animal stem cell therapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global animal stem cell therapy market, including VetStem Biopharma, Aratana Therapeutics, and Medrego, focus on innovation, clinical research, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stem cell therapies, improve cell processing techniques, and expand the clinical applications of regenerative medicine in veterinary healthcare. Collaborations with veterinary clinics, research institutions, and biotech firms facilitate market access and promote technology adoption. Moreover, emphasis on clinical validation, patient education, and regulatory approvals fosters market growth and enhances treatment outcomes in the rapidly evolving veterinary regenerative medicine sector.

Key Companies Profiled:

• VetStem Biopharma
• Aratana Therapeutics
• Medrego
• Cell Therapy Sciences
• Vetbiologics
• Magellan Stem Cells
• Stemcell Vet UK
• Regeneus Ltd.
• Vetherapy
• Animal Cell Therapies, Inc.

Animal Stem Cell Therapy Market Segmentation

By Product Type

• Hemopoietic Stem Cells
• Mesenchymal Stem Cells

By Source

• Allogeneic Animal Stem Cell Therapy
• Autologous Animal Stem Cell Therapy

By Application

• Osteoarthritis
• Soft Tissue Injuries
• Traumatic Fractures
• Tendonitis
• Inflammatory Bowel Disease

By Species

• Canine
• Feline
• Equine

By End User

• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Research Institutes

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Animal Stem Cell Therapy Market Outlook
• 1.2. Global Animal Stem Cell Therapy Market Outlook: Services
• 1.3. Introduction/Key Findings
• 1.4. Historical Market Size (US$ Mn) and Analysis, By Services, 2019-2024
• 1.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Services, 2025-2032
• 1.6. Key Market Trends
• 1.7. Future Market Projections
• 1.8. Premium Market Insights
• 1.9. Industry Developments and Key Market Events
• 1.10. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Product Adoption Analysis
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Global Animal Stem Cell Therapy Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 4.3. Global Animal Stem Cell Therapy Market Outlook: Product Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 4.3.3.1. Hemopoietic Stem Cells
    • 4.3.3.2. Mesenchymal Stem Cells
  • 4.3.4. Market Attractiveness Analysis: Product Type
• 4.4. Global Animal Stem Cell Therapy Market Outlook: Source
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Source, 2019-2024
  • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 4.4.3.1. Allogeneic Animal Stem Cell Therapy
    • 4.4.3.2. Autologous Animal Stem Cell Therapy
  • 4.4.4. Market Attractiveness Analysis: Source
• 4.5. Global Animal Stem Cell Therapy Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Osteoarthritis
    • 4.5.3.2. Soft Tissue Injuries
    • 4.5.3.3. Traumatic Fractures
    • 4.5.3.4. Tendonitis
    • 4.5.3.5. Inflammatory Bowel Disease
    • 4.5.3.6. Others
  • 4.5.4. Market Attractiveness Analysis: Application
• 4.6. Global Animal Stem Cell Therapy Market Outlook: Species
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Species, 2019-2024
  • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 4.6.3.1. Canine
    • 4.6.3.2. Feline
    • 4.6.3.3. Equine
  • 4.6.4. Market Attractiveness Analysis: Species
• 4.7. Global Animal Stem Cell Therapy Market Outlook: End User
  • 4.7.1. Introduction / Key Findings
  • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 4.7.3.1. Veterinary Hospitals
    • 4.7.3.2. Veterinary Clinics
    • 4.7.3.3. Veterinary Research Institutes
  • 4.7.4. Market Attractiveness Analysis: End User

5. Global Animal Stem Cell Therapy Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Animal Stem Cell Therapy Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Product Type
  • 6.2.3. By Source
  • 6.2.4. By Application
  • 6.2.5. By Species
  • 6.2.6. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 6.4.1. Hemopoietic Stem Cells
  • 6.4.2. Mesenchymal Stem Cells
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
  • 6.5.1. Allogeneic Animal Stem Cell Therapy
  • 6.5.2. Autologous Animal Stem Cell Therapy
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Osteoarthritis
  • 6.6.2. Soft Tissue Injuries
  • 6.6.3. Traumatic Fractures
  • 6.6.4. Tendonitis
  • 6.6.5. Inflammatory Bowel Disease
  • 6.6.6. Others
• 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 6.7.1. Canine
  • 6.7.2. Feline
  • 6.7.3. Equine
• 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 6.8.1. Veterinary Hospitals
  • 6.8.2. Veterinary Clinics
  • 6.8.3. Veterinary Research Institutes
• 6.9. Market Attractiveness Analysis

7. Europe Animal Stem Cell Therapy Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product Type
  • 7.2.3. By Source
  • 7.2.4. By Application
  • 7.2.5. By Species
  • 7.2.6. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 7.4.1. Hemopoietic Stem Cells
  • 7.4.2. Mesenchymal Stem Cells
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
  • 7.5.1. Allogeneic Animal Stem Cell Therapy
  • 7.5.2. Autologous Animal Stem Cell Therapy
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Osteoarthritis
  • 7.6.2. Soft Tissue Injuries
  • 7.6.3. Traumatic Fractures
  • 7.6.4. Tendonitis
  • 7.6.5. Inflammatory Bowel Disease
  • 7.6.6. Others
• 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.7.1. Canine
  • 7.7.2. Feline
  • 7.7.3. Equine
• 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.8.1. Veterinary Hospitals
  • 7.8.2. Veterinary Clinics
  • 7.8.3. Veterinary Research Institutes
• 7.9. Market Attractiveness Analysis

8. East Asia Animal Stem Cell Therapy Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product Type
  • 8.2.3. By Source
  • 8.2.4. By Application
  • 8.2.5. By Species
  • 8.2.6. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 8.4.1. Hemopoietic Stem Cells
  • 8.4.2. Mesenchymal Stem Cells
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
  • 8.5.1. Allogeneic Animal Stem Cell Therapy
  • 8.5.2. Autologous Animal Stem Cell Therapy
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Osteoarthritis
  • 8.6.2. Soft Tissue Injuries
  • 8.6.3. Traumatic Fractures
  • 8.6.4. Tendonitis
  • 8.6.5. Inflammatory Bowel Disease
  • 8.6.6. Others
• 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.7.1. Canine
  • 8.7.2. Feline
  • 8.7.3. Equine
• 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.8.1. Veterinary Hospitals
  • 8.8.2. Veterinary Clinics
  • 8.8.3. Veterinary Research Institutes
• 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Animal Stem Cell Therapy Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product Type
  • 9.2.3. By Source
  • 9.2.4. By Application
  • 9.2.5. By Species
  • 9.2.6. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 9.4.1. Hemopoietic Stem Cells
  • 9.4.2. Mesenchymal Stem Cells
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
  • 9.5.1. Allogeneic Animal Stem Cell Therapy
  • 9.5.2. Autologous Animal Stem Cell Therapy
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Osteoarthritis
  • 9.6.2. Soft Tissue Injuries
  • 9.6.3. Traumatic Fractures
  • 9.6.4. Tendonitis
  • 9.6.5. Inflammatory Bowel Disease
  • 9.6.6. Others
• 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.7.1. Canine
  • 9.7.2. Feline
  • 9.7.3. Equine
• 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.8.1. Veterinary Hospitals
  • 9.8.2. Veterinary Clinics
  • 9.8.3. Veterinary Research Institutes
• 9.9. Market Attractiveness Analysis

10. Latin America Animal Stem Cell Therapy Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product Type
  • 10.2.3. By Source
  • 10.2.4. By Application
  • 10.2.5. By Species
  • 10.2.6. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 10.4.1. Hemopoietic Stem Cells
  • 10.4.2. Mesenchymal Stem Cells
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
  • 10.5.1. Allogeneic Animal Stem Cell Therapy
  • 10.5.2. Autologous Animal Stem Cell Therapy
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Osteoarthritis
  • 10.6.2. Soft Tissue Injuries
  • 10.6.3. Traumatic Fractures
  • 10.6.4. Tendonitis
  • 10.6.5. Inflammatory Bowel Disease
  • 10.6.6. Others
• 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.7.1. Canine
  • 10.7.2. Feline
  • 10.7.3. Equine
• 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.8.1. Veterinary Hospitals
  • 10.8.2. Veterinary Clinics
  • 10.8.3. Veterinary Research Institutes
• 10.9. Market Attractiveness Analysis

11. Middle East & Africa Animal Stem Cell Therapy Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product Type
  • 11.2.3. By Source
  • 11.2.4. By Application
  • 11.2.5. By Species
  • 11.2.6. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 11.4.1. Hemopoietic Stem Cells
  • 11.4.2. Mesenchymal Stem Cells
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
  • 11.5.1. Allogeneic Animal Stem Cell Therapy
  • 11.5.2. Autologous Animal Stem Cell Therapy
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Osteoarthritis
  • 11.6.2. Soft Tissue Injuries
  • 11.6.3. Traumatic Fractures
  • 11.6.4. Tendonitis
  • 11.6.5. Inflammatory Bowel Disease
  • 11.6.6. Others
• 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.7.1. Canine
  • 11.7.2. Feline
  • 11.7.3. Equine
• 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.8.1. Veterinary Hospitals
  • 11.8.2. Veterinary Clinics
  • 11.8.3. Veterinary Research Institutes
• 11.9. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Aratana Therapeutics, Inc.
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. VetStem, Inc.
  • 12.3.3. Magellan Stem Cells
  • 12.3.4. StemcellX
  • 12.3.5. Boehringer Ingelheim (Global stem cell technology)
  • 12.3.6. Cell Therapy Sciences
  • 12.3.7. VETherapy Corporation
  • 12.3.8. MediVet Biologics LLC (Ardent Animal Health)
  • 12.3.9. Medrego
  • 12.3.10. AniCell Biotech
  • 12.3.11. Gallant
  • 12.3.12. Companion Animal Health
  • 12.3.13. Kintaro Cells Power
  • 12.3.14. StemBioSys
  • 12.3.15. Regen BioPharma, Inc.
  • 12.3.16. Celltex Therapeutics Corporation
  • 12.3.17. Regenexx

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations

관련자료